EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study
Go back to EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study| (NASDAQ: EYEG) | Delayed: 34.86 -0.08 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.94 | 52 Week High | $5.09 | |||
| Open | $34.86 | 52 Week Low | $1.11 | |||
| Day High | $34.86 | P/E | N/A | |||
| Day Low | $34.86 | EPS | $0.00 | |||
| Volume | 110 | |||||

